on 28 Mar 2023
Last Applicant/ Owned by
SUITE 610
DALLAS
TX
75235
Serial Number
88267270 filed on 18th Jan 2019
Registration Number
7012668 registered on 28th Mar 2023
Correspondent Address
Christopher M. Kindel
Filing Basis
1. intent to use
2. use application currently
Disclaimer
"IMMUNE SENSOR THERAPEUTICS"
Color is not claimed as a feature of the mark. The mark consists of the wording "IMMUNESENSOR" with a stylized letter "S" in the design of a DNA helix at the beginning of the word "SENSOR" and the word "THERAPEUTICS" below the word "SENSOR". Pharmaceutical preparations for use in humans for the treatment of cancer and immunological diseases; pharmaceutical preparations for the treatment of canceRead More
Chemicals and biological preparations for use in the biological, biotechnological, medical, and pharmaceutical industries; Medicinal and biological preparations for research, laboratory, and medical laboratory use, namely, preparations used in the manufacture of pharmaceuticals for treating cancer and immunological diseases
28th Nov 2022
28th Nov 2022
Pharmaceutical preparations for use in humans for the treatment of cancer and immunological diseases; pharmaceutical preparations for the treatment of cancer and for use in oncology
07th Dec 2022
07th Dec 2022
Biotechnology research, namely, research and development of pharmaceutical preparations for use in humans; Medical research; Research and development of pharmaceutical preparations for the treatment of cancer and immunological diseases; Providing medical and scientific research information in the fields of pharmaceuticals, biologicals, and clinical trials
01st Feb 2020
01st Feb 2020
No 88267270
No Service Mark
No IMMU004US
No
No
No
No
No
No
No
No
26.01.29 -
Helixes
27.03.05 -
Representations of objects forming letters or numerals, including punctuation
The mark consists of the wording "IMMUNESENSOR" with a stylized letter "S" in the design of a DNA helix at the beginning of the word "SENSOR" and the word "THERAPEUTICS" below the word "SENSOR".
| Status Date | Action Taken |
|---|---|
| 28th Mar 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 28th Mar 2023 | REGISTERED-PRINCIPAL REGISTER |
| 21st Feb 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 20th Feb 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 27th Jan 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| 26th Jan 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 27th Dec 2022 | USE AMENDMENT FILED |
| 27th Dec 2022 | TEAS STATEMENT OF USE RECEIVED |
| 12th Jul 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 08th Jul 2022 | SOU EXTENSION 4 GRANTED |
